Deutsche Bank Ag\ Edgewise Therapeutics, Inc. Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

A detailed history of Deutsche Bank Ag\ transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 217,882 shares of EWTX stock, worth $7.12 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

217,882

Previous 31,114 600.27%

Holding current value

$7.12 Million

Previous $560,000 938.39%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$15.88 - $29.5 $2.97 Million - $5.51 Million	186,768 Added 600.27%	217,882 $5.82 Million
Q2 2024 Aug 14, 2024	BUY	$15.08 - $21.23 $88,067 - $123,983	5,840 Added 23.11%	31,114 $560,000
Q1 2024 May 15, 2024	BUY	$9.25 - $19.97 $44,992 - $97,134	4,864 Added 23.83%	25,274 $460,000
Q4 2023 Feb 14, 2024	SELL	$5.51 - $12.1 $3,785 - $8,312	-687 Reduced 3.26%	20,410 $223,000
Q3 2023 Nov 09, 2023	BUY	$5.73 - $7.69 $18,204 - $24,431	3,177 Added 17.73%	21,097 $120,000
Q2 2023 Aug 14, 2023	SELL	$5.71 - $10.29 $32,415 - $58,416	-5,677 Reduced 24.06%	17,920 $138,000
Q1 2023 May 15, 2023	BUY	$6.66 - $11.33 $46,353 - $78,856	6,960 Added 41.83%	23,597 $157,000
Q4 2022 Feb 13, 2023	BUY	$7.58 - $11.08 $34,663 - $50,668	4,573 Added 37.91%	16,637 $148,000
Q3 2022 Nov 14, 2022	SELL	$8.08 - $13.58 $16,087 - $27,037	-1,991 Reduced 14.17%	12,064 $119,000
Q2 2022 Aug 11, 2022	SELL	$5.67 - $9.87 $45,025 - $78,377	-7,941 Reduced 36.1%	14,055 $112,000
Q1 2022 May 13, 2022	SELL	$9.1 - $18.97 $22,731 - $47,387	-2,498 Reduced 10.2%	21,996 $214,000
Q4 2021 Feb 11, 2022	BUY	$14.41 - $22.41 $246,756 - $383,748	17,124 Added 232.35%	24,494 $374,000
Q3 2021 Nov 04, 2021	BUY	$14.11 - $24.1 $352 - $602	25 Added 0.34%	7,370 $122,000
Q2 2021 Aug 11, 2021	BUY	$21.33 - $30.25 $156,668 - $222,186	7,345 New	7,345 $156,000

Others Institutions Holding EWTX

# of Institutions

191

Shares Held

100M

Call Options Held

2.17M

Put Options Held

410K

View Full List

About Edgewise Therapeutics, Inc.

Ticker EWTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 63,171,700
Market Cap $2.07B
Description
Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...

More about EWTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account